Academic Journal

The silica-based sorbents for the mixed-mode extraction of risdiplam and its metabolite from serum samples.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: The silica-based sorbents for the mixed-mode extraction of risdiplam and its metabolite from serum samples.
Συγγραφείς: Balińska N; Chair of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University in Toruń, 7 Gagarin Str., PL-87-100, Toruń, Poland., Lemska A; Department of Developmental Neurology, Medical University of Gdansk, 7 Dębinki Str., PL-80-952, Gdańsk, Poland., Mazurkiewicz-Bełdzińska M; Department of Developmental Neurology, Medical University of Gdansk, 7 Dębinki Str., PL-80-952, Gdańsk, Poland., Studzińska S; Chair of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University in Toruń, 7 Gagarin Str., PL-87-100, Toruń, Poland. Electronic address: kowalska@umk.pl.
Πηγή: Journal of chromatography. A [J Chromatogr A] 2026 Aug 30; Vol. 1783, pp. 467210. Date of Electronic Publication: 2026 Jun 23.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9318488 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3778 (Electronic) Linking ISSN: 00219673 NLM ISO Abbreviation: J Chromatogr A Subsets: MEDLINE
Imprint Name(s): Original Publication: Amsterdam ; New York : Elsevier, 1993-
Ιατρικοί όροι (MeSH): Solid Phase Extraction*/methods , Silicon Dioxide*/chemistry, Chromatography, High Pressure Liquid/methods ; Methanol/chemistry ; Reproducibility of Results ; Hydrogen-Ion Concentration ; Humans ; Hydrophobic and Hydrophilic Interactions ; Limit of Detection
Περίληψη: Analysis of risdiplam and its main metabolite is critical for pharmacokinetic studies and therapeutic drug monitoring in spinal muscular atrophy. However, current analytical methods face challenges due to low analyte stability, limited selectivity, and pronounced matrix effects, with only four studies published to date. In this work, a comprehensive analytical strategy was developed for the first time, combining optimized chromatographic separation with a novel sample preparation approach. The effects of methanol content, salt concentration, and pH on retention, peak symmetry, and resolution were systematically investigated. Chromatographic conditions were optimized using a central composite design, enabling rapid selection of mobile phase and achieving efficient separation of both compounds within 3.5 min. General trends in mobile phase composition were identified, indicating optimal performance at either low salt concentration and high pH or high salt concentration and low pH. For sample preparation, dispersive solid-phase extraction was introduced using newly synthesized hydrophobic and mixed-mode sorbents designed to provide hydrophobic, π-π, electrostatic, and hydrogen-bonding interactions. The extraction procedure was extensively optimized with respect to sorbent type and elution conditions (solvent composition and the addition of salt, formic acid, or ammonia). Compared with conventional non-polar sorbents, mixed-mode materials containing alkylamide, benzoic acid, cholesterol, and residual aminopropyl groups demonstrated superior recoveries and reproducibility. Finally, an alkylamide sorbent with acidified methanol-water elution was selected. The method enabled direct extraction from serum without protein precipitation, yielding recoveries of 86% and 53% for risdiplam and its metabolite, respectively. The proposed strategy provides a robust, selective, and efficient approach for risdiplam bioanalysis.
(Copyright © 2026 Elsevier B.V. All rights reserved.)
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Contributed Indexing: Keywords: Dispersive solid phase extraction (dSPE); High performance liquid chromatography; Hydrophobic-hydrophilic sorbents; Metabolite; Risdiplam; Serum
Substance Nomenclature: 7631-86-9 (Silicon Dioxide)
Y4S76JWI15 (Methanol)
Entry Date(s): Date Created: 20260625 Date Completed: 20260629 Latest Revision: 20260629
Update Code: 20260630
DOI: 10.1016/j.chroma.2026.467210
PMID: 42349182
Βάση Δεδομένων: MEDLINE